Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid-In Capital [Member]	Other Comprehensive Gain/(Loss) [Member]	Accumulated Deficit [Member]	Noncontrolling Interest [Member]
Beginning balance at Dec. 31, 2023	$ 90,470	$ 63	$ 558,692	$ (74)	$ (468,023)	$ (188)
Beginning balance, Shares at Dec. 31, 2023		63,286,404
Issuance of common stock upon release of restricted stock units, Shares		22,111
Issuance of common stock from at-the-market offerings, net of offering costs	8,643	$ 5	8,638
Issuance of common stock from at the market offerings, net of offering costs, Shares		5,045,518
Stock-based compensation	740		740
Net unrealized loss on investments, net of tax	(84)			(84)
Net (loss) gain	(15,487)				(15,491)	4
Ending balance at Mar. 31, 2024	84,282	$ 68	568,070	(158)	(483,514)	(184)
Ending balance, Shares at Mar. 31, 2024		68,354,033
Beginning balance at Dec. 31, 2024	69,832	$ 84	602,021	(40)	(532,046)	(187)
Beginning balance, Shares at Dec. 31, 2024		84,038,922
Issuance of common stock upon release of restricted stock units, Shares		21,108
Issuance of common stock from at-the-market offerings, net of offering costs	18,757	$ 5	18,752
Issuance of common stock from at the market offerings, net of offering costs, Shares		4,941,895
Issuance of common stock upon exercise of stock options	$ 2		2
Issuance of common stock upon exercise of stock options, Shares	900	900
Stock-based compensation	$ 1,178		1,178
Net unrealized loss on investments, net of tax	(26)			(26)
Net (loss) gain	(14,881)				(14,880)	(1)
Ending balance at Mar. 31, 2025	$ 74,862	$ 89	$ 621,953	$ (66)	$ (546,926)	$ (188)
Ending balance, Shares at Mar. 31, 2025		89,002,825